This inventor holds 2 USPTO granted patents. Top assignees: The University of New Mexico, Torrey Pines Institute for Molecular Studies. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016-2018
Title: José Medina-Franco: Innovator in Biochemical Research
Introduction
José Medina-Franco, hailing from Port St. Lucie, Florida, is a distinguished inventor with a focus on innovative solutions in the field of biochemical research. With a total of two patents to his name, Medina-Franco is known for his groundbreaking work involving formylpeptide receptors, which have significant implications in pharmaceutical development.
Latest Patents
Medina-Franco's latest patents include novel methods and assays for high-throughput screening of combinatorial libraries aimed at identifying FPR1 and/or FPR2 ligands. The invention emphasizes the importance of positional scanning deconvolution to discover high-affinity small molecule ligands, focusing on both agonists and antagonists. These advancements not only contribute to the understanding of FPR1 and FPR2-related disorders but also pave the way for related pharmaceutical compositions and treatment methods.
Career Highlights
Throughout his career, José has contributed to several prestigious organizations, including the University of New Mexico and the Torrey Pines Institute for Molecular Studies. His expertise and dedication have led to impactful advancements in the field, making him a notable figure in biochemical research.
Collaborations
Medina-Franco has collaborated with esteemed colleagues such as Bruce S. Edwards and Larry A. Sklar. These partnerships further enhance the depth and breadth of his research, enabling progression in the study of molecular interactions and therapeutic applications.
Conclusion
José Medina-Franco's contributions to the field of biochemical research, marked by his patents and collaborative endeavors, reflect a commitment to innovation and a desire to improve healthcare outcomes. His work continues to inspire future research and development within the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile